Search
+

    Healthcare players welcome government's decision to allow vaccine for all above 45 years

    Synopsis

    In a tweet, Biocon's Kiran Mazumdar-Shaw said, "From April 1, vaccine for all those who're 45 or older - a welcome decision that is gradually progressing towards the rest of the general population. By August 15 we will truly celebrate independence from COVID-19."

    Reuters
    Healthcare and biopharma players have welcomed the government's decision to allow all people above 45 years of age to get COVID-19 vaccine from April 1, and said it will enhance the pace of vaccination. FICCI immediate past president and Apollo Hospitals Group Joint MD Sangita Reddy welcomed the government's decision to lower the age criteria for COVID-19 vaccination.

    In a tweet, Reddy said, "This is a welcome step and will enhance the pace of vaccination. I request the government to further reduce the age eligibility criteria to 20 years."

    Executive Chairperson Kiran Mazumdar-Shaw also called it a welcome decision.

    In a tweet, she said, "From April 1, vaccine for all those who're 45 or older - a welcome decision that is gradually progressing towards the rest of the general population. By August 15 we will truly celebrate independence from COVID-19."
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Read before you invest. Insights on Biocon Ltd.. Explore Now
    The Economic Times

    Stories you might be interested in